JP2006525316A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525316A5
JP2006525316A5 JP2006507486A JP2006507486A JP2006525316A5 JP 2006525316 A5 JP2006525316 A5 JP 2006525316A5 JP 2006507486 A JP2006507486 A JP 2006507486A JP 2006507486 A JP2006507486 A JP 2006507486A JP 2006525316 A5 JP2006525316 A5 JP 2006525316A5
Authority
JP
Japan
Prior art keywords
agent component
active agent
dosage form
adverse
transdermal dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006507486A
Other languages
English (en)
Japanese (ja)
Other versions
JP4897479B2 (ja
JP2006525316A (ja
Filing date
Publication date
Priority claimed from US10/744,996 external-priority patent/US7182955B2/en
Application filed filed Critical
Publication of JP2006525316A publication Critical patent/JP2006525316A/ja
Publication of JP2006525316A5 publication Critical patent/JP2006525316A5/ja
Application granted granted Critical
Publication of JP4897479B2 publication Critical patent/JP4897479B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006507486A 2003-04-30 2004-03-23 濫用抵抗性経皮的剤形 Expired - Fee Related JP4897479B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46723503P 2003-04-30 2003-04-30
US60/467,235 2003-04-30
US10/744,996 US7182955B2 (en) 2003-04-30 2003-12-23 Abuse-resistant transdermal dosage form
US10/744,996 2003-12-23
PCT/US2004/008857 WO2004098576A1 (en) 2003-04-30 2004-03-23 Abuse-resistant transdermal dosage form

Publications (3)

Publication Number Publication Date
JP2006525316A JP2006525316A (ja) 2006-11-09
JP2006525316A5 true JP2006525316A5 (https=) 2007-05-10
JP4897479B2 JP4897479B2 (ja) 2012-03-14

Family

ID=33313651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507486A Expired - Fee Related JP4897479B2 (ja) 2003-04-30 2004-03-23 濫用抵抗性経皮的剤形

Country Status (6)

Country Link
US (1) US7182955B2 (https=)
EP (1) EP1620080B1 (https=)
JP (1) JP4897479B2 (https=)
AU (2) AU2004237580A1 (https=)
CA (1) CA2523425A1 (https=)
WO (1) WO2004098576A1 (https=)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
RS20050812A (sr) * 2003-04-30 2007-12-31 Purdue Pharma L.P., Transdermalni dozni oblik otporan na promene
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
WO2006023644A2 (en) * 2004-08-20 2006-03-02 3M Innovative Properties Company Transdermal drug delivery device with translucent protective film
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US7827983B2 (en) * 2004-12-20 2010-11-09 Hewlett-Packard Development Company, L.P. Method for making a pharmaceutically active ingredient abuse-prevention device
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
EP1968539A2 (en) * 2005-12-13 2008-09-17 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
US7740879B2 (en) * 2006-01-17 2010-06-22 Harrogate Holdings Abuse resistant transdermal drug delivery patch
US8790678B2 (en) * 2006-03-03 2014-07-29 Washington University Biomaterials having nanoscale layers and coatings
DE102006025282A1 (de) 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
US20110150766A1 (en) * 2006-07-07 2011-06-23 Royds Robert B Transdermal patch with fatal overdose protection
DK2054031T3 (en) 2006-07-21 2016-05-17 Biodelivery Sciences Int Inc Transmucosal delivery devices with improved uptake
ES2350416T3 (es) * 2007-08-21 2011-01-21 Lts Lohmann Therapie-Systeme Ag Procedimiento para la confección de varias pistas de parches terapéuticos transdermales.
WO2009106831A2 (en) * 2008-02-28 2009-09-03 Syntropharma Limited Pharmaceutical composition
DE102008016804B4 (de) 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
DE102009036485B4 (de) 2009-08-07 2012-10-04 Lts Lohmann Therapie-Systeme Ag Mittel zur zerstörenden Entsorgung von medizinischen Wirkstoffen in transdermalen therapeutischen Systemen
JP2013523780A (ja) * 2010-04-02 2013-06-17 オールトランツ インコーポレイティド オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑止性経皮製剤
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
AU2012296346A1 (en) 2011-08-18 2014-04-03 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
EA201491164A1 (ru) * 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
WO2014145699A1 (en) * 2013-03-15 2014-09-18 New Jersey Institute Of Technology System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process
AP2015008920A0 (en) 2013-06-04 2015-12-31 Lohmann Therapie Syst Lts Transdermal delivery system
ES2921990T3 (es) 2014-09-10 2022-09-05 Bard Inc C R Apósito protector para un dispositivo médico colocado en la piel
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
EP3434267B1 (en) 2016-03-24 2023-07-26 MEDRx Co., Ltd. Patch preparation having misuse prevention characteristics
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US9731103B1 (en) 2017-01-13 2017-08-15 Berkshire Biomedical, LLC Computerized oral prescription administration devices and associated systems and methods
US10792226B2 (en) 2017-06-07 2020-10-06 Berkshire Biomedical, LLC Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices
US10441509B2 (en) 2018-03-16 2019-10-15 Berkshire Biomedical, LLC Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
WO2020009685A1 (en) 2018-07-02 2020-01-09 John Tang Transdermal dosage form
WO2020008370A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal patch
WO2020008366A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal dosage form
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
AU2019402149A1 (en) * 2018-12-18 2021-06-24 Johnson & Johnson Consumer Inc. Personalized topical application patch
US10729860B1 (en) 2019-05-22 2020-08-04 Berkshire Biomedical, LLC Computerized oral prescription administration for securely dispensing a medication and associated systems and methods
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1602344A (en) * 1924-01-09 1926-10-05 Eagle Peter Medicating compress
US2807262A (en) * 1952-12-10 1957-09-24 Robert B Lew Perforated plastic adhesive tape bandage
US3773955A (en) 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
US4457933A (en) 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4539256A (en) 1982-09-09 1985-09-03 Minnesota Mining And Manufacturing Co. Microporous sheet material, method of making and articles made therewith
JPS5959734A (ja) * 1982-09-30 1984-04-05 Nitto Electric Ind Co Ltd 液状活性物質含有膜及びその製造方法
US4693776A (en) 1985-05-16 1987-09-15 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
DE3722775A1 (de) 1987-07-09 1989-01-19 Lohmann Therapie Syst Lts Transdermales therapeutisches system
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH01254621A (ja) * 1988-04-01 1989-10-11 Terumo Corp 薬剤担体および徐放性薬剤ならびにそれらの製造方法
US5236714A (en) 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
ES2141261T3 (es) 1993-10-29 2000-03-16 Minnesota Mining & Mfg Adhesivos piezosensibles con superficies microestructuradas.
US5494680A (en) 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
WO1997004835A1 (de) 1995-07-28 1997-02-13 Novartis Ag Transdermales system
JPH09151138A (ja) * 1995-11-29 1997-06-10 Toray Ind Inc 薬剤徐放性積層体
US6103258A (en) 1996-04-12 2000-08-15 Simon; David Lew Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6-Methylenemorphinan-3,14 diol molecule for optimizing dopamine homeostasis during administration of opioid analgesics
US5985317A (en) 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US20020119187A1 (en) 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
ES2270746T3 (es) 2001-03-16 2007-12-01 Alza Corporation Parche transdermico para administrar fentanilo.
DK2062573T3 (da) 2001-05-01 2012-01-30 Euro Celtique Sa Misbrugsresistent opioid indeholdende transdermale systemer
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
JP2005515960A (ja) 2001-05-11 2005-06-02 エンドー ファーマシューティカルズ， インコーポレイティド 乱用耐性のオピオイド投薬形態
AU2002313628A1 (en) 2001-05-22 2002-12-03 Euro-Celtique Tamper resistant oral dosage form
AU2002339378A1 (en) 2001-05-22 2002-12-03 Euro-Celtique Compartmentalized dosage form
AU2002324624A1 (en) 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
ATE431738T1 (de) 2001-08-06 2009-06-15 Euro Celtique Sa Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
JP2005526839A (ja) * 2002-04-23 2005-09-08 アルザ・コーポレーシヨン 不正使用の可能性が低い経皮鎮痛薬システム
SI1530469T1 (sl) 2002-08-20 2009-06-30 Euro Celtique Sa Transdermalna odmerna oblika, ki obsega aktivno sredstvo in antagonist v obliki soli in v obliki proste baze
RS20050812A (sr) 2003-04-30 2007-12-31 Purdue Pharma L.P., Transdermalni dozni oblik otporan na promene

Similar Documents

Publication Publication Date Title
JP2006525316A5 (https=)
del Consuelo et al. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl
US6465709B1 (en) Exothermic bandage
ES2245649T3 (es) Un sistema de entrega de farmaco dual adhesivo transdermico.
JP2006525315A5 (https=)
US9849270B2 (en) Foldable adhesive composite dressing
TWI454249B (zh) 用於治療或預防甲癬或足癬之壓敏膠黏劑基質藥貼裝置
JPWO1995016440A1 (ja) 経皮投与用パッチ製剤
WO2007116959A1 (ja) マイクロニードルデバイスおよびマイクロニードル付き経皮薬物投与装置
CN1170360A (zh) 具有粘性贴面和剥离密封圆片的经皮输送系统
JP2018513121A5 (https=)
WO2005112984A3 (en) Apparatus and method for transdermal delivery of parathyroid hormone agents
CN101146523B (zh) 透皮给药系统
JP5137286B2 (ja) フェンタニル含有口腔粘膜貼付剤
JPH0679002A (ja) 経皮投与用パッチシステム
JP2002531488A5 (https=)
JPH08502727A (ja) プリントされた経皮薬剤送達デバイス
WO2004012676A3 (en) Drug-loaded biological material chemically treated with genipin
WO2004098568A3 (en) Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
TW200602099A (en) Apparatus and method for transdermal delivery of fentanyl-based agents
KR101583680B1 (ko) 펜타닐의 1일-1회 교체 경피 투여
US20070248657A1 (en) Multi-compartment transdermal pain control device
JP2010528064A (ja) 経皮タバコアルカロイドリザーバパッチ
WO2006089056A3 (en) Apparatus and method for transdermal delivery of erythropoetin-based agents
EP1753412A1 (en) Self-heating pharmaceutical patch